# Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects

> **NCT02576353** · PHASE1 · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 50 (actual)

## Conditions studied

- Pharmacokinetics and Pharmacodynamics

## Interventions

- **DRUG:** Fentanyl
- **DRUG:** Fentanyl Citrate

## Key facts

- **NCT ID:** NCT02576353
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576353, "Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02576353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*